NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease
- PMID: 32296063
- PMCID: PMC7109024
- DOI: 10.1038/s41392-020-0145-7
NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment on
-
NLRP3 inflammasome activation drives tau pathology.Nature. 2019 Nov;575(7784):669-673. doi: 10.1038/s41586-019-1769-z. Epub 2019 Nov 20. Nature. 2019. PMID: 31748742 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
